Streetbeat News

RDTCF

Rapid Dose Therapeutics Corp

Industry

Surgical and Medical Instrument Manufacturing

Open

0.01

Mkt cap

23M

Volume

10K

High

0.18

P/E Ratio

-6.05

52-wk high

0.39

Low

0.01

Div yield

N/A

52-wk low

0.00

Rapid Dose Therapeutics Corp. (OTCPK:RDTCF) (CSE:DOSE) reported a 59% decrease in revenue for FY23, with a net comprehensive loss of CA$3.8 million. The company established B2B partnerships to sell their nutraceutical products in Canadian retail stores and entered into a pharmaceutical collaboration with Skycare Compounding Labs. However, they faced regulatory approval hurdles and delays for product applications in Europe, USA, and Canada.

Portfolio Pulse from Vuk Zdinjak

June 29, 2023 | 2:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.